The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI
- PMID: 32114522
- DOI: 10.1515/hmbci-2019-0058
The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI
Abstract
Background The aim of this study was to analyze two different polymorphisms, Ser680Asn and -29 (G>A) promoter polymorphism, of the follicle-stimulating hormone receptor (FSHR) gene, individually but also in combination, in a sample of Greek women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Materials and methods One hundred and forty-one women undergoing IVF or ICSI and 94 controls were genotyped by real-time polymerase chain reaction (RT-PCR) for the two FSHR polymorphisms. The association of the alleles with the clinical, biochemical and other parameters concerning the controlled ovarian stimulation (COS) protocol and outcome was investigated, as well as the pregnancy rate. Results The study of each polymorphism individually revealed a positive correlation of the SerSer genotype (Ser680Asn polymorphism) with higher luteinizing hormone (LH) levels on the third day of the menstrual cycle. On the other hand, the A allele for the -29 (G>A) promoter polymorphism correlated with the increased number and quality of cumulus-oocyte complexes (COCs). No differences were detected when the different genotypes of the two polymorphisms were combined - the population study was grouped according to the number of polymorphic alleles they carried (0-4 alleles). Women who presented all polymorphic alleles, AsnAsn/AA, exhibited the lowest LH levels (2.62 ± 0.68 mIU/L), but were rarely detected (n = 2, 1.4% of the studied population). Conclusions The data from this study reflect that the investigation of the combination of polymorphisms, such as FSHR -29 and Ser680Asn, could offer a valuable tool in order to evaluate and anticipate the outcome of the ovulation induction protocols, especially in the group of patients with failed attempts.
Keywords: -29 promoter region; FSHR gene polymorphisms; ICSI; IVF; Ser680Asn.
Similar articles
-
Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.J Reprod Med. 2013 Sep-Oct;58(9-10):395-401. J Reprod Med. 2013. PMID: 24050028
-
Combined study on the single nucleotide polymorphisms in the follicle-stimulating hormone receptor (Ser680Asn) and anti-Müllerian hormone receptor type II (-482A>G) as genetic markers in assisted reproduction.Horm Mol Biol Clin Investig. 2019 Mar 25;38(1). doi: 10.1515/hmbci-2018-0077. Horm Mol Biol Clin Investig. 2019. PMID: 30904901
-
The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.Clin Endocrinol (Oxf). 2015 Apr;82(4):577-83. doi: 10.1111/cen.12573. Epub 2014 Oct 3. Clin Endocrinol (Oxf). 2015. PMID: 25132286
-
Pharmacogenetics in ovarian stimulation--current concepts.Ann N Y Acad Sci. 2008 Apr;1127:10-9. doi: 10.1196/annals.1434.001. Ann N Y Acad Sci. 2008. PMID: 18443324 Review.
-
Highly Purified Human Menopausal Gonadotropin (Menopur®): A Profile of Its Use in Infertility.Clin Drug Investig. 2018 Nov;38(11):1077-1084. doi: 10.1007/s40261-018-0703-8. Clin Drug Investig. 2018. PMID: 30264288 Review.
Cited by
-
Significance of FSHR and LHCGR gene polymorphisms on clinical outcomes in gonadotropin-releasing hormone antagonist protocol with freeze-all strategy: A case-control study.Int J Reprod Biomed. 2024 Sep 12;22(7):539-552. doi: 10.18502/ijrm.v22i7.16962. eCollection 2024 Jul. Int J Reprod Biomed. 2024. PMID: 39355311 Free PMC article.
-
The Role of FSHR SNPs and AMH in Follicular Fluid and Serum in Ovarian Response during COS: A Pilot Study.Int J Reprod Med. 2021 Feb 9;2021:8685158. doi: 10.1155/2021/8685158. eCollection 2021. Int J Reprod Med. 2021. PMID: 33628769 Free PMC article.
-
Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response-A Genetic Survey.J Clin Med. 2021 Jan 6;10(2):170. doi: 10.3390/jcm10020170. J Clin Med. 2021. PMID: 33561079 Free PMC article. Review.
-
Recent advances in understanding gonadotropin signaling.Fac Rev. 2021 Apr 19;10:41. doi: 10.12703/r/10-41. eCollection 2021. Fac Rev. 2021. PMID: 34046645 Free PMC article. Review.
-
Effects of FSHR and FSHB Variants on Hormonal Profile and Reproductive Outcomes of Infertile Women With Endometriosis.Front Endocrinol (Lausanne). 2021 Sep 30;12:760616. doi: 10.3389/fendo.2021.760616. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34659133 Free PMC article.
References
-
- Gearhart J, Coutifaris C. In vitro fertilization, the Nobel Prize, and human embryonic stem cells. Cell Stem Cell. 2011;8:12–5.
-
- George JW, Dille EA, Heckert LL. Current concepts of follicle-stimulating hormone receptor gene regulation. Biol Reprod. 2011;84:7–17.
-
- Gromoll J, Simoni M. Genetic complexity of FSH receptor function. Trends Endocrinol Metab. 2005;16:368–73.
-
- Simoni M, Casarini L. Mechanisms in endocrinology: genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol. 2014;170:R91–107.
-
- Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365–9.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical